Nutrileno Pharmaceutical Private Limited
About Nutrileno Pharmaceutical Private Limited
Data last updated:
Nutrileno Pharmaceutical Private Limited is a private limited company based in Thrissur, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24230KL2015PTC039697. Its GSTIN is 32AAFCN4142E1ZY (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Seema Akkodapily and Sunil Kumar Ollukara Govindan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Xx/338/12(1) 2nd Floor Presidency Building, Thrissur, Kerala, India – 680004.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.89 Lakh, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹53,995 (net margin 5.5%) and EBITDA of ₹94,992 (EBITDA margin 9.6%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nutrileno Pharmaceutical Private Limited's registered office is in Thrissur, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressXx/338/12(1) 2nd Floor Presidency Building, Thrissur, Kerala, India – 680004
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nutrileno Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nutrileno Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Nutrileno Pharmaceutical Private Limited, buy the company report.
Financials of Nutrileno Pharmaceutical Private Limited
FY 2025 filings availableNutrileno Pharmaceutical Private Limited reported revenue of ₹9.89 Lakh (up 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 37% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA rose 159% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹94,992 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹53,995 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.6% | ||||
| Net Profit Margin | 5.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nutrileno Pharmaceutical Private Limited, buy the company report.
Board of directors of Nutrileno Pharmaceutical Private Limited
Nutrileno Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seema Akkodapily | Director | 11 Dec 2015 | 10 Years 10 Months | Current |
| Sunil Kumar Ollukara Govindan Also directs: Innopolis Bio Innovations Private Limited | Director | 08 Mar 2021 | 5 Years 7 Months | Current |
Auditor
Nutrileno Pharmaceutical Private Limited is audited by ROHITH CHANDRAN & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ROHITH CHANDRAN & ASSOCIATES | FY 2021 | 012654S |
Shareholding
The shareholding of Nutrileno Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nutrileno Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nutrileno Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nutrileno Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nutrileno Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAFCN4142E1ZY | Kerala | Active | 13 Nov 2017 |
To see the full GST registrations and return filing status of Nutrileno Pharmaceutical Private Limited, buy the company report.
Recent activity
Nutrileno Pharmaceutical Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Shreeja Sasidharanpillai ceased to be Managing Director on 08 Mar 2021.
Frequently asked questions
Nutrileno Pharmaceutical is an active private limited company based in Thrissur, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 December 2015 (11+ years old) and is registered under CIN U24230KL2015PTC039697.
Nutrileno Pharmaceutical has 2 current directors:
- Seema Akkodapily - Director
- Sunil Kumar Ollukara Govindan - Director
The latest financial statements of Nutrileno Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Nutrileno Pharmaceutical is 32AAFCN4142E1ZY, registered in Kerala.
The CIN (Corporate Identification Number) of Nutrileno Pharmaceutical is U24230KL2015PTC039697. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nutrileno Pharmaceutical was incorporated on 11 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Ernakulam.
Shreeja Sasidharanpillai ceased to be Managing Director on 08 Mar 2021. Sunil Kumar Ollukara Govindan was appointed as Director on 08 Mar 2021. Seema Akkodapily was appointed as Director on 11 Dec 2015.
The registered office of Nutrileno Pharmaceutical is at Xx338121 2nd Floor Presidency Building, Thrissur, Kerala, India – 680004.
Nutrileno Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Nutrileno Pharmaceutical is compliant as of 20 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
